The New York Times published a great editorial supporting a ban on much of the lavish treatment that doctors get from drug reps. If adopted by medical schools, restrictions would include:
- Ban on personal gifts, industry-supplied foods and meals, free travel (not reimbursed for services), and payment for attending industry-sponsored meetings
- Ban on ghostwriting, the practice of drug companies drafting an article and then getting a doc to slap his or her name on it making it look at though the doc actually wrote it
- Drug samples would have to be submitted to a central pharmacy not individual doctors
The restrictions, however, end there. The editorial says the proposal goes far but not far enough.
Patients need to be assured that their doctors are prescribing what’s best for them, not what’s best for companies.
Can someone get a doctor to read this?